120 related articles for article (PubMed ID: 35978138)
1. Applying a genetic risk score for prostate cancer to men with lower urinary tract symptoms in primary care to predict prostate cancer diagnosis: a cohort study in the UK Biobank.
Green HD; Merriel SWD; Oram RA; Ruth KS; Tyrrell J; Jones SE; Thirlwell C; Weedon MN; Bailey SER
Br J Cancer; 2022 Nov; 127(8):1534-1539. PubMed ID: 35978138
[TBL] [Abstract][Full Text] [Related]
2. Genetic sequence variants are associated with severity of lower urinary tract symptoms and prostate cancer susceptibility.
Helfand BT; Hu Q; Loeb S; McVary KT; Catalona WJ
J Urol; 2013 Mar; 189(3):845-8. PubMed ID: 23159463
[TBL] [Abstract][Full Text] [Related]
3. Impact of lower urinary tract symptoms on prostate cancer risk among Japanese men with prostate-specific antigen <10 ng/mL and non-suspicious digital rectal examination.
Ito M; Masuda H; Kawakami S; Fujii Y; Koga F; Saito K; Yamamoto S; Yonese J; Fukui I; Kihara K
Int J Urol; 2013 Dec; 20(12):1163-8. PubMed ID: 23521022
[TBL] [Abstract][Full Text] [Related]
4. Assessment of lower urinary tract symptoms in men by international prostate symptom score and core lower urinary tract symptom score.
Fujimura T; Kume H; Nishimatsu H; Sugihara T; Nomiya A; Tsurumaki Y; Miyazaki H; Suzuki M; Fukuhara H; Enomoto Y; Homma Y
BJU Int; 2012 May; 109(10):1512-6. PubMed ID: 21883834
[TBL] [Abstract][Full Text] [Related]
5. Sleep Problems are Associated with Development and Progression of Lower Urinary Tract Symptoms: Results from REDUCE.
Branche BL; Howard LE; Moreira DM; Roehrborn C; Castro-Santamaria R; Andriole GL; Hopp ML; Freedland SJ
J Urol; 2018 Feb; 199(2):536-542. PubMed ID: 28870861
[TBL] [Abstract][Full Text] [Related]
6. Statin Use and Lower Urinary Tract Symptoms Incidence and Progression in Reduction by Dutasteride of Prostate Cancer Events (REDUCE) Trial.
Kramer JJ; Gu L; Moreira D; Andriole G; Csizmadi I; Freedland SJ
J Urol; 2022 Feb; 207(2):417-423. PubMed ID: 34544265
[TBL] [Abstract][Full Text] [Related]
7. Serum cholesterol and risk of lower urinary tract symptoms progression: Results from the Reduction by Dutasteride of Prostate Cancer Events study.
Feng T; Howard LE; Vidal AC; Moreira DM; Castro-Santamaria R; Andriole GL; Freedland SJ
Int J Urol; 2017 Feb; 24(2):151-156. PubMed ID: 28004415
[TBL] [Abstract][Full Text] [Related]
8. PSA predicts development of incident lower urinary tract symptoms: results from the REDUCE study.
Patel DN; Feng T; Simon RM; Howard LE; Vidal AC; Moreira DM; Castro-Santamaria R; Roehrborn C; Andriole GL; Freedland SJ
Prostate Cancer Prostatic Dis; 2018 Jun; 21(2):238-244. PubMed ID: 29795141
[TBL] [Abstract][Full Text] [Related]
9. Urodynamics tests for the diagnosis and management of bladder outlet obstruction in men: the UPSTREAM non-inferiority RCT.
Lewis AL; Young GJ; Selman LE; Rice C; Clement C; Ochieng CA; Abrams P; Blair PS; Chapple C; Glazener CM; Horwood J; McGrath JS; Noble S; Taylor GT; Lane JA; Drake MJ
Health Technol Assess; 2020 Sep; 24(42):1-122. PubMed ID: 32902375
[TBL] [Abstract][Full Text] [Related]
10. Radical prostatectomy improves and prevents age dependent progression of lower urinary tract symptoms.
Prabhu V; Taksler GB; Sivarajan G; Laze J; Makarov DV; Lepor H
J Urol; 2014 Feb; 191(2):412-7. PubMed ID: 23954581
[TBL] [Abstract][Full Text] [Related]
11. Performance of Three Inherited Risk Measures for Predicting Prostate Cancer Incidence and Mortality: A Population-based Prospective Analysis.
Shi Z; Platz EA; Wei J; Na R; Fantus RJ; Wang CH; Eggener SE; Hulick PJ; Duggan D; Zheng SL; Cooney KA; Isaacs WB; Helfand BT; Xu J
Eur Urol; 2021 Mar; 79(3):419-426. PubMed ID: 33257031
[TBL] [Abstract][Full Text] [Related]
12. Relationship between lifestyle and health factors and severe lower urinary tract symptoms (LUTS) in 106,435 middle-aged and older Australian men: population-based study.
Smith DP; Weber MF; Soga K; Korda RJ; Tikellis G; Patel MI; Clements MS; Dwyer T; Latz IK; Banks E
PLoS One; 2014; 9(10):e109278. PubMed ID: 25333345
[TBL] [Abstract][Full Text] [Related]
13. Lower urinary tract symptoms (LUTS) are not associated with an increased risk of prostate cancer in men 50-69 years with PSA ≥3 ng/ml.
Chandra Engel J; Palsdottir T; Aly M; Egevad L; Grönberg H; Eklund M; Nordström T
Scand J Urol; 2020 Feb; 54(1):1-6. PubMed ID: 31876229
[No Abstract] [Full Text] [Related]
14. The effect of benign lower urinary tract symptoms on subsequent prostate cancer testing and diagnosis.
Weight CJ; Kim SP; Jacobson DJ; McGree ME; Boorjian SA; Thompson RH; Leibovich BC; Karnes RJ; St Sauver J
Eur Urol; 2013 Jun; 63(6):1021-7. PubMed ID: 23313032
[TBL] [Abstract][Full Text] [Related]
15. EAU Guidelines on the Assessment of Non-neurogenic Male Lower Urinary Tract Symptoms including Benign Prostatic Obstruction.
Gratzke C; Bachmann A; Descazeaud A; Drake MJ; Madersbacher S; Mamoulakis C; Oelke M; Tikkinen KAO; Gravas S
Eur Urol; 2015 Jun; 67(6):1099-1109. PubMed ID: 25613154
[TBL] [Abstract][Full Text] [Related]
16. Does Prostate Size Predict the Development of Incident Lower Urinary Tract Symptoms in Men with Mild to No Current Symptoms? Results from the REDUCE Trial.
Simon RM; Howard LE; Moreira DM; Roehrborn C; Vidal AC; Castro-Santamaria R; Freedland SJ
Eur Urol; 2016 May; 69(5):885-91. PubMed ID: 26724841
[TBL] [Abstract][Full Text] [Related]
17. Poor clinical guideline adherence and inappropriate testing for incident lower urinary tract symptoms associated with benign prostatic hyperplasia.
Welliver C; Feinstein L; Ward JB; Kirkali Z; Martinez-Miller EE; Matlaga BR; McVary K
Prostate Cancer Prostatic Dis; 2022 Feb; 25(2):269-273. PubMed ID: 34545201
[TBL] [Abstract][Full Text] [Related]
18. Single-Nucleotide Polymorphism-Based Genetic Risk Score and Patient Age at Prostate Cancer Diagnosis.
Na R; Labbate C; Yu H; Shi Z; Fantus RJ; Wang CH; Andriole GL; Isaacs WB; Zheng SL; Helfand BT; Xu J
JAMA Netw Open; 2019 Dec; 2(12):e1918145. PubMed ID: 31880795
[TBL] [Abstract][Full Text] [Related]
19. Chronic Prostate Inflammation is Associated with Severity and Progression of Benign Prostatic Hyperplasia, Lower Urinary Tract Symptoms and Risk of Acute Urinary Retention.
Nickel JC; Roehrborn CG; Castro-Santamaria R; Freedland SJ; Moreira DM
J Urol; 2016 Nov; 196(5):1493-1498. PubMed ID: 27378134
[TBL] [Abstract][Full Text] [Related]
20. Drug treatment patterns for the management of men with lower urinary tract symptoms associated with benign prostatic hyperplasia who have both storage and voiding symptoms: a study using the health improvement network UK primary care data.
Hakimi Z; Johnson M; Nazir J; Blak B; Odeyemi IA
Curr Med Res Opin; 2015 Jan; 31(1):43-50. PubMed ID: 25333647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
